Last edition
News about "CDMO"
Akums Drugs and Pharmaceuticals Reports 35.4 Percent EBITDA Growth in Q1 FY27
Akums Drugs and Pharmaceuticals starts FY27 on a strong note, reporting robust revenue, EBITDA and PAT growth as its CDMO business continues to drive performance.
CDMO | 11/08/2026 | By News Bureau
Gland Pharma and Neuland Partner for Sterile API Manufacturing
Gland Pharma and Neuland Laboratories have partnered to expand sterile Active Pharmaceutical Ingredient (API) manufacturing through a new state-of-the-art current Good Manufacturing Practice (GMP) sterile manufacturing suite.
CDMO | 06/08/2026 | By News Bureau
Piramal Pharma Reports Q1 FY27 Results
Piramal Pharma has reported its standalone and consolidated Q1 FY27 financial results, highlighting its performance for the quarter ended June 30, 2026.
CDMO | 30/07/2026 | By News Bureau
Shilpa Biologicals has launched PartnerPower, a proprietary platform offering real-time visibility into process development and Good Manufacturing Practice (GMP) manufacturing, setting a new benchmark for transparency in CDMO operations.
CDMO | 24/06/2026 | By News Bureau
Made Scientific and Pluristyx Partner to Advance iPSC Cell Therapies
Made Scientific and Pluristyx have launched a strategic partnership to streamline iPSC-derived cell therapy development and manufacturing. By integrating Pluristyx’s clinical-grade iPSC platform with Made Scientific’s CDMO services, the collaboration provides developers with a single-source pathway from cell line development to commercial supply.
CDMO | 08/06/2026 | By News Bureau | 135
OrganaBio Acquires Excellos Assets to Establish Bicoastal Cell Therapy Manufacturing Platform
The acquisition expands cGMP manufacturing, PBMC isolation and cryopreservation capabilities across the US to support cell therapy developers from preclinical to commercial stages.
CDMO | 16/05/2026 | By News Bureau | 107
OneSource and Orbicular Receive US FDA Tentative Approval for Generic Semaglutide
OneSource and Orbicular secure US FDA tentative approval for generic semaglutide injection, advancing ANDA filing for Ozempic with manufacturing support from OneSource.
CDMO | 22/04/2026 | By News Bureau | 244
Morepen Laboratories Bags Zero-Observation USFDA Inspection for Fourth Time
Morepen Laboratories clears its fourth consecutive USFDA inspection at the Masulkhana facility with zero observations (NIL 483), reinforcing its CDMO strength following a INR 825 crore global manufacturing mandate.
CDMO | 21/04/2026 | By News Bureau | 338
Piramal Pharma Solutions Expands ADC Capabilities with Ajinomoto Bio-Pharma Services Pact
Piramal Pharma Solutions partners with Ajinomoto Bio-Pharma Services to accelerate ADC development and manufacturing, enabling access to AJICAP technology.
CDMO | 20/04/2026 | By News Bureau | 162
Symbiosis Pharmaceutical Services Appoints Joanne Anderson as Chief Commercial Officer
Symbiosis Pharmaceutical Services has appointed Joanne Anderson as CCO, tasking her with leading global commercial strategy as the CDMO expands capacity and strengthens presence across North America and Europe.
CDMO | 13/03/2026 | By News Bureau | 150
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy